Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism
- 1 August 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 116 (2), 505-508
- https://doi.org/10.1016/0002-8703(88)90625-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.Circulation, 1987
- Rapid Detection of Cross-Linked Fibrin Degradation Products in Plasma Using Monoclonal Antibody-Coated Latex ParticlesAmerican Journal of Clinical Pathology, 1986
- Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systemsBritish Journal of Haematology, 1985
- Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.Journal of Clinical Pathology, 1984
- An immunoassay for human D dimer using monoclonal antibodiesThrombosis Research, 1983
- VENTILATION-PERFUSION STUDIES AND THE DIAGNOSIS OF PULMONARY-EMBOLISM - CONCISE COMMUNICATION1980